Navigation Links
Nanopore method could revolutionize genome sequencing

nanopores were not successful because the twisting and turning of the DNA strand introduced too much noise into the signal being recorded. The new idea takes advantage of the electric field that drives the current perpendicular to the DNA strand to reduce the structural fluctuations of DNA while it moves through the pore, thus minimizing the noise.

"If nature was very unkind, then the DNA would always fluctuate so much as it passes through the nanopore that measuring the current would not give us any information about what base is present at a particular location," explained Michael Zwolak, a graduate student in physics at the California Institute of Technology who contributed to the study. "However, we have identified a particular way to operate the nanopore/electrode system that suppresses some of the fluctuations so they aren't so great as to destroy the distinguishability of the bases."

The researchers caution that there are still hurdles to overcome because no one has yet made a nanopore with the required configuration of electrodes, but they think it is only a matter of time before someone successfully assembles the device. The nanopore and the electrodes have been made separately, and although it is technically challenging to bring them together, the field is advancing so rapidly that they think it should be possible in the near future.

In addition to the speed and low cost of the nanopore method, the researchers calculate that it will ultimately be significantly less error-prone than current methods.

"The DNA sequencing method we propose has the potential of having fewer errors than the present method, which is based on the Sanger method," said Johan Lagerqvist, a graduate student in physics at UCSD and the lead author on the paper. "It should be possible to sequence strands of DNA that are tens of thousands of base pairs in length, possibly as long as an entire gene, in one pass through the nanopore. With the Sanger
'"/>

Source:University of California - San Diego


Page: 1 2 3

Related biology news :

1. Color-blind method opens new doors in DNA sequencing
2. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
3. Studies reveal methods viruses use to sidestep immune system
4. An entropy-based gene selection method for cancer classification using microarray data
5. New methods of gene delivery using lasers
6. Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications
7. Shift of weather patterns necessitates rethinking of reforestation methods
8. Scientists use manufacturing methods to reconstruct mastodon
9. Researchers develop promising new gene network analysis method
10. New method shows it is possible to grow bone for grafts within a patients body
11. Researchers develop new method for facile identification of proteins in bacterial cells
Post Your Comments:
(Date:12/16/2009)... 7 IgeaCare Solutions Inc. is pleased ... the healthcare communications company previously operating as IgeaCare ... now move forward under new leadership and funding. ... Rochon to the position of Chief Executive Officer. ... on providing a superior servicing and support model; ...
(Date:12/16/2009)... CSC (NYSE: CSC ... for Laboratory Accreditation awarded the International Organization ... to the company,s Test Lab, which is ... in Fairmont, W.Va. The Test Lab is ... world to achieve this accomplishment. ,, ...
(Date:12/15/2009)... Mo. As soon as babies are born, ... jaundice and e-coli. For up to a month, their ... these infections are often minor, they can lead to ... immune systems, University of Missouri researchers have pinpointed a ... to an immune-strengthening vaccine. , "We,re trying to improve ...
Breaking Biology News(10 mins):IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation 2Researchers work on vaccine to improve immune system in newborns 2Post transplant combo can replace toxic immune suppressing drugs in monkeys 51106 1Post transplant combo can replace toxic immune suppressing drugs in monkeys 51106 2Springer launches SpringerImages 9172 1Springer launches SpringerImages 9172 2LoJack SafetyNet and Project Lifesaver Help Rescue Clients Afflicted With Alzheimers Dementia Who Wandered 51100 1LoJack SafetyNet and Project Lifesaver Help Rescue Clients Afflicted With Alzheimers Dementia Who Wandered 51100 2LoJack SafetyNet and Project Lifesaver Help Rescue Clients Afflicted With Alzheimers Dementia Who Wandered 51100 3LoJack SafetyNet and Project Lifesaver Help Rescue Clients Afflicted With Alzheimers Dementia Who Wandered 51100 4LoJack SafetyNet and Project Lifesaver Help Rescue Clients Afflicted With Alzheimers Dementia Who Wandered 51100 5
... Through studying pigeons with genetic heart disease, researchers at ... clue about why some patients' heart vessels are prone ... identified a regulator of genes that controls the growth ... senior researcher. "Learning to modulate the uncontrolled growth of ...
... A Northwestern University research group has discovered that ... is critical to proper embryo formation. , ... in the advanced online issue of the journal ... unstable embryonic growth factor by injecting aggressive melanoma ...
... Methylphenidate (Ritalin) elevates norepinephrine levels in the brains ... nerve signal transmissions in the sensory pathways to ... a Philadelphia research team has found. , Their ... how a stimulant aids people with attention deficit ...
Other Biology News:Pigeons provide clue to solving common problem in heart patients 2Malignant melanoma cells secrete protein required for embryo formation 2Ritalin packs punch by elevating norepinephrine, suppressing nerve signal transmissions 2Ritalin packs punch by elevating norepinephrine, suppressing nerve signal transmissions 3
(Date:12/16/2009)... in the Nation ,, PHILADELPHIA, Dec. 16 ... has been granted Magnet(R) recognition by the American ... is one of the highest levels of recognition ... places Hahnemann among the five percent of hospitals ... distinction. ,, At 9:00 am on Monday, Hahnemann ...
(Date:12/16/2009)... -- Decision Resources, one of the world,s leading ... issues, finds that, according to responses from surveyed ... (both interleukin inhibitors) will capture 22 percent of ... market for moderate to severe psoriasis. Among these ... nearly three times as much patient share as ...
(Date:12/16/2009)... for the ultimate CHO cell culture supplement? InVitria has what ... cell culture media supplement that improves the growth and productivity ... culture performance, Zap-CHO is an animal free, well defined and ... ... Fort Collins, CO (PRWEB) December 16, 2009 -- Scientists working ...
(Date:12/15/2009)... MARINO, Calif., Dec. 15 Epeius Biotechnologies ... targeted genetic medicine, gained international validation of the ... Rexin-G , when scientists around the world rediscovered ... a major locus of cancer pathogenesis and disease ... therapies. Recently, scientists at the NIH National Cancer ...
Breaking Biology Technology:Hahnemann University Hospital Granted Magnet(R) Status 2Hahnemann University Hospital Granted Magnet(R) Status 3In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3
... Orexigen(R) Therapeutics,Inc. (Nasdaq: OREX ), a biopharmaceutical company ... obesity, today announced,that the Company will be presenting at ... the Biotech Industry Thursday, September 4, 2008, 10:00 ... UBS Global Life Sciences Conference Tuesday, September ...
... Mass., Aug. 28 RainDance Technologies, Inc.,a provider ... research, today announced a collaboration with the Scripps,Translational ... as a solution to a key bottleneck in ... support STSI in its exciting effort to discover,inherited ...
... 28 Barr Pharmaceuticals,Inc. (NYSE: BRL ) ... final approval from the U.S. Food & Drug ... of Ortho McNeil Janssen,s,Razadyne(R) (galantamine hydrobromide), 4 mg, ... launch its generic Razadyne tablets product immediately., ...
Other Biology Technology:RainDance and Scripps to Collaborate on Targeted Sequencing for 'Wellderly' Study 2RainDance and Scripps to Collaborate on Targeted Sequencing for 'Wellderly' Study 3RainDance and Scripps to Collaborate on Targeted Sequencing for 'Wellderly' Study 4RainDance and Scripps to Collaborate on Targeted Sequencing for 'Wellderly' Study 5Barr Receives Approval for Generic Version of Razadyne(R) Tablets 2Barr Receives Approval for Generic Version of Razadyne(R) Tablets 3Barr Receives Approval for Generic Version of Razadyne(R) Tablets 4Barr Receives Approval for Generic Version of Razadyne(R) Tablets 5